Cynosure, the Cutera-owned aesthetic device subsidiary, has launched XERF, a next-generation monopolar RF platform, in European markets. The platform targets the growing demand for non-invasive skin tightening, positioning itself as a clinical and commercial alternative to existing monopolar RF systems like InMode's Morpheus8 and Lumenis' Thermage.
Devices & Tech
Cynosure Launches XERF Monopolar RF Platform in Europe — Next-Gen Skin Tightening Enters Market
Cutera's subsidiary rolls out next-generation monopolar RF technology targeting non-invasive skin tightening demand across the continent.

1-YEAR MOVE
INMD
▲1.0%
| Ticker | Company | 1-year change |
|---|---|---|
| INMD | InMode Ltd. | +1.0% |